CR Double-Crane announced that the company and some of its subsidiaries participated in the 11th batch of national centralized drug procurement, and some products are expected to be selected. The drugs expected to be selected include Metoclopramide Injection, Meprobamate Injection, Famotidine Injection, and Piracetam Oral Immediate Release Formulation. Among them, the expected selected price for Metoclopramide Injection is 0.68 yuan per vial, for Meprobamate Injection is 9.78 yuan per vial, for Famotidine Injection is 0.42 yuan per vial, and for Piracetam Oral Immediate Release Formulation is 7.87 yuan per bottle